Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 5 Fib (1.6-2.0 g/L) level and serum index before and after treatment (mean ± SD)

		Fib (g/L)	PT (s)	PLT (109/L)	TBIL (μmol/L)	ALB (g/L)
Research group 30 cases	Before treatment	1.68 ± 0.18	20.52 ± 3.12	69.07 ± 32.57	104.51 ± 65.26	32.79 ± 4.69
	After treatment	1.95 ± 0.43	17.66 ± 2.38	80.10 ± 42.12	34.44 ± 17.10	36.32 ± 3.98
Control group 30 cases	Before treatment	1.72 ± 0.15	21.01 ± 3.31	83.60 ± 56.41	126.97 ± 61.69	33.47 ± 3.72
	After treatment	1.64 ± 0.44	19.07 ± 7.13	67.63 ± 42.65	113.60 ± 163.86	35.69 ± 5.21
P value		< 0.0001	< 0.0001	0.259	0.008	0.604

PT, Fib and TBIL were significantly higher in the research group than in the control group after treatment.